Auro Laboratories Ltd

NSE: AUROLAB · BSE: 530233 · Pharmaceuticals & Biotechnology · 15 announcements

Auro Laboratories Ltd news stories on ALFA NewsRead the news →

Share price: ₹232.50
Market cap: ₹144.9 Cr
Revenue (annual): ₹32.61 Cr
Net profit (annual): ₹3.53 Cr
P/E (TTM): 30.9×Sector 47.4×
Promoter holding: 52.40%+0.22% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 3 Regulatory Approval 2 Other Announcement 2 Management Change 2 Board Meeting Date 2 Annual General Meeting 2 Credit Rating 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

14 Apr 2026 18:16 IST BSE

Credit Rating

Auro Laboratories Credit Rating

Auro Laboratories Limited received new credit ratings from Acuite Ratings & Research Limited for ₹79.80 Crore in bank facilities. Long-term facilities were assigned 'ACUITE BB+' and short-term facilities 'ACUITE A4+', both with a 'Stable' outlook. The ratings reflect the promoters' extensive experience and a moderate financial risk profile despite recent capex-related revenue declines.

Value: ₹79.80 Cr

Read the filing ↗